DDIS-05. IDENTIFICATION OF 2-FLUORO PALMITIC ACID AS A POTENTIAL THERAPEUTIC AGENT AGAINST GLIOBLASTOMA

BACKGROUND: Glioblastoma (GBM) represents the most aggressive and frequent type of primary malignant brain tumors with a dismal clinical outcome. Though adjuvant temozolomide (TMZ) chemotherapy followed by surgical resection can extend patient`s post-operative survival, a considerable number of GBM...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Jiapaer, Shabierjiang, Dong, Yu, Kitabayashi, Tomohiro, Furuta, Taskuya, Sabit, Hemragul, Zhang, Jiakang, Zhang, guangtao, Tanaka, Shingo, Nakada, Mitsutoshi
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2019
Assuntos:
Drug Discovery
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847336/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.265
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares